Chiron rejects $4.5 billion Novartis takeover bid

September 09 2005

U.S. biotech Chiron has rejected a $4.5 billion takeover bid proposed last week by the Swiss drug giant Novartis.

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.